Introduction
============

Cervical cancer is the third most common cancer after breast and colorectal cancer and the fourth leading cause of death among women in Malaysia(1-3). It remains to be one of the major cancers that burden worldwide particularly in under-developed and developing countries (Cervical cancer incidence rate increased with age after 30 years and has its peak at ages 65-69 years. According to ethnicity in Malaysia, women of Indian ethnic group have the highest incidence for cervical cancer followed by Chinese and Malay ([@ref3]). Majority Malays are Muslims, thus lower incidence of this cancer was observed. In Iran, the incidence of cervical cancer is remarkably low since the dominant residents are Muslims. There are almost no extramarital sexual relations and they depend strongly on family-based traditions ([@ref7]).

The survival rate of cervical cancer patients may vary by country. The five-year survival exceeded 70% in Korea ([@ref8]--[@ref10]), 55% in Turkey ([@ref11]) and it can be as low as 17% which was in Uganda ([@ref12]). There were various prognostic factors established in many studies such as stage, age, lymph node involvement and tumor size ([@ref13]--[@ref16]). In Kentucky, between January 2001 and May 2010, a study of 381 cervical cancer patients who were referred to tertiary care centre found that stage of disease was a significant prognostic factor for overall survival ([@ref17]). Meanwhile, a study of 44,182 patients diagnosed with cervical cancer between 1993 and 2002 in Korea, found that both stage and histological type of cervical cancer were important factors for survival ([@ref18]).

To our knowledge, studies on survival of cervical cancer patients in Malaysia are somewhat limited. The analysis from published studies was often limited to the frequently used Cox proportional hazard regression model when examining the relationship of the survival distribution to covariates ([@ref17], [@ref19]--[@ref21]). This is perhaps due to the fact that although baseline hazard is not specified in Cox model, the parameter can still be estimated. The objective of this study was to determine the effects of explanatory variables on the survival of cervical cancer patients using parametric regression model. In some cases, parametric models are more informative than the Cox model such as the baseline hazard and survival estimates are known (can be estimated). Several examples of parametric models can be found in the following studies ([@ref22]--[@ref27]). Zhu et al. have compared the Cox and Weibull model in modeling the gastric cancer data and found that the Weibull model gave more a precise results in than the Cox model ([@ref28]). The Weibull model has gained popularity in modeling survival data due to its flexibility in the shape parameter that can accommodate a decreasing, constant and increasing hazard. Furthermore, the suitability of the Weibull model can be easily assessed using a log-cumulative hazard plot.

In this study, a stratified Weibull model was used since there was a time-dependent covariate that caused the proportional hazard assumption vio-lated.

Materials and Methods
=====================

The study design was retrospective in nature in which patients' records were reviewed retrospectively to obtain the data. The cervical cancer data was taken from *Hospital UniversitiSains Malaysia* (HUSM). The HUSM, located in Kubang Kerian, Kelantan has been long regarded as the referral centre for the East Coast region of Malaysia. The inclusion criteria were histopathologically and clinically diagnosed with cancer of cervix between 1^st^ July 1995 and 30^th^ June 2007, and received at least one treatment related to cervical cancer in HUSM. Patients who were died due to other competing causes of death (not cervical cancer), or with incomplete data were excluded from this study. One hundred and twenty patients who have fulfilled the inclusion criteria were identified. Ethical clearance was obtained from research and ethics committee of University Sains Malaysia (reference number: USMKK/PPP/JEPeM \[205.4 (2.4)\]).

The variable of interest was time (in months) which was measured from the patient was diagnosed with cervical cancer up to the time of death. Factors that were considered in the analysis were ethnicity (non Malay, Malay), lymph node involvement (negative, positive), metastasis (with metastasis, without metastasis), histology (squamous cell carcinoma, adeno cell carcinoma), primary treatment (surgery, radiotherapy and/or chemotherapy), age at diagnosis (\<40, 40 -- 59, ≥ 60) and stage (stage I & II, stage III & IV). International Federation of Gynecology and Obstetrics (FIGO) system was used in staging patients with cervical cancer. Data analysis was performed using the statistical package TIBCO Spotfire S-Plus version 8.1. The suitability of the Weibull model for the data was assessed using a plot of the log of the negative log of the estimated survivor function against log time or log-cumulative hazard plot. Univariate analysis was conducted using the simple Weibull regression analysis to identify the possible prognostic factors individually. Significant factors from the univariate analysis were further analyzed by the Weibull multivariate analysis to model the prognostic factors. Model selection procedure was based on the forward variable selection method with statistical significance set at *α* = 0.10. The proportionality of the hazards was assessed using the test based on Schoenfeld ([@ref29]). As the proportional hazard assumption was not satisfied, a stratified model was used instead ([@ref30]) and in measuring the goodness of fit of the model, deviance residuals were used. [Fig. 1](#F1){ref-type="fig"} shows a study flow diagram which summarizes the steps of the statistical analysis performed.
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Results
=======

The log-cumulative hazard plotshows a straight line which suggests that the distribution of survival time considered follows Weibull distribution ([Fig. 2](#F2){ref-type="fig"}). Patients' characteristics and the incidence rate ratio were tabulated in [Table 1](#T1){ref-type="table"}. About 74% of total patients were presented at stage I & II. The ratio of the risk of death for patients who were diagnosed in stage III & IV compared to the risk of death for patients in group stage I & II was 1.44. Meanwhile, the risk of dying of patients in with metastasis group was 1.55, greater than patients who had no metastasis.

The results from the univariate analysis are presented in [Table 2](#T2){ref-type="table"}. From this analysis, three factors were statistically significant namely, stage, metastasis and primary treatment. Based on the forward selection procedure in multivariate analysis, two variables namely stage and metastasis was found to be significant factors ([Table 3](#T3){ref-type="table"}). However, it was noted that metastasis (*P*=0.032) did not satisfy the proportional hazard assumption and a stratified model was then considered. It is worthwhile to note that while the stratification allows separate baseline hazard function to each metastasis group, the coefficient of the predictor variables are assumed to be the same within each metastasis group ([@ref29]). The first stratum consists of patients without metastasis and the second stratum were patients who do have metastasis. Parameter estimates of the stratified model were performed and the output is given in [Table 4](#T4){ref-type="table"}.
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###### 

Characteristics of patients treated in HUSM (n=120)

  Variables                                  No. of patients   Percentage (%)   Incidence rate ratio
  ------------------------------------------ ----------------- ---------------- ----------------------
  **Ethnicity**                                                                 
      **Non malay**                          21                17.5             
      **Malay**                              99                82.5             1.19
  **Lymph node involvement**                                                    
      **Negative**                           89                74.2             
      **Positive**                           31                25.8             0.92
  **Metastasis**                                                                
      **without metastasis**                 83                69.2             
      **with metastasis**                    37                30.8             1.55
  **Histologic type**                                                           
      **Squamous cell carcinoma**            93                77.5             
      **Adeno cell carcinoma**               27                22.5             1.29
  **Age at diagnosis**                                                          
      **\< 40**                              2                 1.7              
      **40-59**                              97                80.8             0.56
      **≥ 60**                               21                17.5             0.48
  **Stage**                                                                     
      **I & II**                             89                74.2             
      **III & IV**                           31                25.8             1.44
  **Primary Treatment**                                                         
      **Surgery**                            40                33.3             
      **Radiotherapy and/or chemotherapy**   80                66.7             1.33

###### 

Univariate analysis of Weibull model with prognostic factors

  Variables                                  Coefficient (*β*)   *χ*^2^   Degree of freedom   *P*-value
  ------------------------------------------ ------------------- -------- ------------------- -----------
  **Ethnicity**                                                                               
      **Non malay**                                                                           
      **Malay**                              −0.205              0.34     1                   0.560
  **Lymph node involvement**                                                                  
      **Negative**                                                                            
      **Positive**                           −0.130              0.21     1                   0.650
  **Metastasis**                                                                              
      **without metastasis**                                                                  
      **with metastasis**                    0.731               7.82     1                   0.005
  **Histologic type**                                                                         
      **Squamous cell carcinoma**                                                             
      **Adeno cell carcinoma**               0.384               1.81     1                   0.180
  **Stage**                                                                                   
      **I & II**                                                                              
      **III & IV**                           0.934               10.92    1                   \<0.001
  **Primary Treatment**                                                                       
      **Surgery**                                                                             
      **Radiotherapy and/or chemotherapy**   0.827               9.38     1                   0.009
  **Age at diagnosis**                                                                        
      **\<40**                                                                                
      **40-59**                              −0.810                                           
      **≥ 60**                               −0.831              1.01     2                   0.600

###### 

Multivariate analysis of Weibull model with prognostic factors

  Variable                     Coefficient (α)   *χ*^2^   Degree of freedom   *P*-value
  ---------------------------- ----------------- -------- ------------------- -----------
  **Metastasis**                                                              
      **without metastasis**                                                  
      **with metastasis**      0.892             \-       \-                  \-
  **Stage**                                                                   
      **I & II**                                                              
      **III & IV**             0.686             17.8     2                   \<

###### 

Output of Weibull model under stratification

  Variable          Value    Std. Error   z        *P*-value
  ----------------- -------- ------------ -------- -----------
  **(Intercept)**   4.386    0.158        27.685   \<0.0001
  **Stage**         −0.924   0.244        −3.793   0.0002

###### 

The hazard ratio for variable stage stratified on metastasis

  Stratum                      Coefficient (*β*)   Hazard ratio, (ψ)
  ---------------------------- ------------------- -------------------
                                                   
  **1 = without metastasis**   0.832               2.30
  **2 = with metastasis**      1.261               3.53
                                                   

The estimated scale parameters (*σ*) for the first and second stratum were *σ*~1~ = 1.11 and *σ*~2~ = 0.733 respectively. The risks of death for cervical cancer patients were estimated by finding the regression coefficient (*β~j~*) $$\beta_{j} = - \frac{\alpha}{\sigma_{j}},$$ and the hazard ratio (*ψ~j~*) $$\psi_{j} = exp(\beta_{j}){}$$

where *j* =1,2 denotes the stratum. The estimated coefficient *α* was obtained from the analysis which was equal to -0.924. The result is shown in [Table 5](#T5){ref-type="table"}. For the first stratum, patients who were diagnosed at stage III & IV are at 2.30 times the risk of death as those in stage I & II. Meanwhile, for the second stratum, patients in stage III & IV group were more likely to die (3.53 times) than patients in stage I & II. The index plot of deviance residuals $(r_{D_{i}})$ was performed to identify the presence of subjects who was poorly predicted by the model ([@ref31]). The plot as given in [Fig. 3](#F3){ref-type="fig"} shows that the residuals are roughly symmetrically distributed around zero and most of the residuals are between -2 to 2. Outliers and influential observations are not observed in the plot thus implying a good fit of the model.
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Discussion
==========

In this study, the Weibull model was used instead of the Cox model because the log-cumulative hazard plot has confirmed that the survival time followed the Weibull distribution. Multivariate analysis through forward selection method found that the most feasible model to describe the survival of cervical cancer patients was dependent upon the covariates namely, stage and metastasis. As the metastasis variable did not meet the proportional hazard assumption, the stratified Weibull model was applied. The model was stratified into two strata according to the metastasis variable.

This study found that patients who were diagnosed at stage III & IV have greater risk of death compared to those who were diagnosed at early stage, stage I & II for both stratum, with and without metastasis. It is worthwhile to note that a study of 515 cervical cancer patients by Dueňas-González et al. showed a significant result for advance stage III & IV with adjusted hazard ratio of 1.54 (95% CI= 1.11- 2.14) ([@ref16]), indicating that patients with advanced stage of disease had a 54% higher risk of progression or death at any time than earlier stage patients. Similar findings were also obtained by other studies ([@ref19], [@ref32]--[@ref34]).

Conclusion
==========

After applying the stratified model, this study found that the prognosis of cervical cancer patients was dependent upon the stage at diagnosis. These findings provide useful knowledge on the understanding of the survival of cervical cancer patients. Besides, this study also demonstrates the solution to time-dependent covariates problem, or when the proportional hazards assumption is violated. The limitation of this study was the use of a hospital-based data. Cervical cancer dataset that comprise of the national data may be obtained to give a more general prognosis and a better description of the survival pattern of all cervical cancer patients in Malaysia. Further works can be done to investigate the interaction between covariates, if any.
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